Complete Blood Count | Blood chemistory | Tumor markers | |||
---|---|---|---|---|---|
WBC | 8400 /μL (3300 ~ 8600) | T-P | 4.8 g/dL (6.6 ~ 8.1) | PSA | 1.950 ng/mL (<  4.0) |
RBC | 4.42 × 106/μL (4.4 ~ 5.6) | Alb | 2.8 g/dL (4.1 ~ 5.1) | NSE | 2.1 ng/mL (<  16.3) |
Hb | 13.9 g/dL (13.7 ~ 16.8) | T-Bil | 2.1 mg/dL (0.4 ~ 1.5) |  |  |
Ht | 39.2% (40.7 ~ 50.1) | AST | 1 U/L (13 ~ 30) |  |  |
MCV | 88.7 fL (83.6 ~ 98.2) | ALT | 47 U/L (10 ~ 42) |  |  |
MCH | 31.4 pg (27.5 ~ 33.2) | LD | 749 U/L (124 ~ 222) |  |  |
MCHC | 35.5 g/dL (31.7 ~ 35.3) | γ-GTP | 89 U/L (13 ~ 64) |  |  |
Plt | 81 × 103/μL (158 ~ 348) | CHE | 194 U/L (240 ~ 486) |  |  |
Neutro | 95.4% (38.5 ~ 80.5) | CK | 216 U/L (59 ~ 248) | Urine data | |
Baso | 0.1% (0.2 ~ 1.4) | LDL-C | 46 mg/dL (65 ~ 163) | Glu | (3+) |
Eosino | 0.0% (0.4 ~ 8.6) | HDL-C | 60 mg/dL (38 ~ 90) | Pro | (3+) |
Lymph | 3.1% (18.2 ~ 47.7) | TG | 130 mg/dL (40 ~ 234) | OB | (−) |
Mono | 1.4% (3.3 ~ 9.0) | BUN | 21.6 mg/dL (8 ~ 20) | Nit | (−) |
 |  | Cre | 1.13 mg/dL (0.7 ~ 1.1) | Ket | (−) |
 |  | eGFR | 49 (>  60) | Bil | (−) |
Endocrinological exam. | Na | 141 mEq/L (138 ~ 145) |  |  | |
ACTH | 1402 pg/mL (7.2 ~ 63.3) | K | 2.1 mEq/L (3.6 ~ 4.8) |  |  |
Cortisol | 8.4 μg/dL (7.07 ~ 19.6) | Cl | 91 mEq/L (101 ~ 108) | U-TP | 1712.0 mg/day (<  150) |
TSH | 0.30 μIU/mL (0.35 ~ 4.94) | Ca | 7.6 mg/dL (8.8 ~ 10.1) | U-cortisol | 137.3 μg/day (11 ~ 80) |
F-T3 | < 1.50 pg/mL (1.88 ~ 3.18) | IP | 3.3 mg/dL (2.7 ~ 4.6) | U-MT | 76.0 mg/day (0.04 ~ 0.19) |
F-T4 | 0.58 ng/dL (0.70 ~ 1.48) | UA | 7.1 mg/dL (3.7 ~ 7.8) | U-NMT | 79.8 mg/day (0.09 ~ 0.33) |
AD | 13,071 pg/mL (<  100) | Glucose | 294 mg/dL (73 ~ 109) |  |  |
NAD | 8987 pg/mL (100 ~ 450) | CPR | 2.4 ng/mL (0.61 ~ 2.09) |  |  |
DA | 190 ng/mL (<  20) | HbA1c | 10.0% (4.9 ~ 6.0) |  |  |
PRA | 0.6 ng/mL/h (0.2 ~ 2.3) | GA | 29.2% (11 .0 ~ 16.0) |  |  |
PAC | < 10.0 ng/dL (4.0 ~ 82.1) | CRP | 1.38 mg/dL (0.00 ~ 0.14) |  |  |
DHEA-S | 119 μg/dL (5 ~ 253) | BNP | 261.9 pg/mL (<  18.4) |  |  |
F-testosterone | 6.8 pg/mL (4.6 ~ 16.9) |  |  |  |  |